{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:03:57Z","timestamp":1751083437096,"version":"3.41.0"},"reference-count":24,"publisher":"Jaypee Brothers Medical Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.59556\/japi.73.0963","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T06:21:21Z","timestamp":1751005281000},"page":"57-62","source":"Crossref","is-referenced-by-count":0,"title":["Guillain\u2013Barr\u00e9 Syndrome in India: A Call for Learning and Cohesive Action"],"prefix":"10.59556","volume":"73","author":[{"given":"Mangesh","family":"Tiwaskar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parthasarathy","family":"Muralidharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(1):","key":"key20250627062116_B1","doi-asserted-by":"crossref","first-page":"97.","DOI":"10.1038\/s41572-024-00580-4","article-title":"Guillain\u2013Barr\u00e9 syndrome.","volume":"10","author":"Leonhard","year":"2024;","journal-title":"Nat Rev Dis Primers"},{"issue":"(10280):","key":"key20250627062116_B2","doi-asserted-by":"crossref","first-page":"1214\u2013","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain\u2013Barr\u00e9 syndrome.","volume":"397","author":"Shahrizaila","year":"2021;","journal-title":"Lancet"},{"issue":"(11):","key":"key20250627062116_B3","doi-asserted-by":"crossref","first-page":"3041\u2013","DOI":"10.1093\/brain\/aww247","article-title":"Guillain\u2013Barr\u00e9 syndrome in the 100 years since its description by Guillain, Barr\u00e9 and Strohl.","volume":"139","author":"Hughes","year":"2016;","journal-title":"Brain"},{"issue":"(8093):","key":"key20250627062116_B4","doi-asserted-by":"crossref","first-page":"750\u2013","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy.","volume":"2","author":"Hughes","year":"1978;","journal-title":"Lancet"},{"issue":"(8845):","key":"key20250627062116_B5","first-page":"586\u2013","article-title":"Double-blind trial of intravenous methylprednisolone in Guillain\u2013Barr\u00e9 syndrome. Guillain\u2013Barr\u00e9 Syndrome Steroid Trial Group.","volume":"341","year":"1993;","journal-title":"Lancet"},{"issue":"(Pt 9):","key":"key20250627062116_B6","doi-asserted-by":"crossref","first-page":"2245\u2013","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain\u2013Barr\u00e9 syndrome: a systematic review.","volume":"130","author":"Hughes","year":"2007;","journal-title":"Brain"},{"issue":"(11):","key":"key20250627062116_B7","doi-asserted-by":"crossref","first-page":"671\u2013","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain\u2013Barr\u00e9 syndrome in ten steps.","volume":"15","author":"Leonhard","year":"2019;","journal-title":"Nat Rev Neurol"},{"issue":"(3):","key":"key20250627062116_B8","first-page":"63\u2013","article-title":"A study on neurological manifestations in coronavirus disease 2019 patients admitted to a tertiary care hospital.","volume":"72","author":"Nagubadi","year":"2024;","journal-title":"J Assoc Physicians India"},{"issue":"(10045):","key":"key20250627062116_B9","doi-asserted-by":"crossref","first-page":"717\u2013","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain\u2013Barr\u00e9 syndrome.","volume":"388","author":"Willison","year":"2016;","journal-title":"Lancet"},{"issue":"(1-2):","key":"key20250627062116_B10","doi-asserted-by":"crossref","first-page":"74\u2013","DOI":"10.1016\/j.jns.2012.02.026","article-title":"Residual disability 10 years after falling ill in Guillain\u2013Barr\u00e9 syndrome: a prospective follow-up study.","volume":"317","author":"Forsberg","year":"2012;","journal-title":"J Neurol Sci"},{"issue":"(12):","key":"key20250627062116_B11","doi-asserted-by":"crossref","first-page":"3646\u2013","DOI":"10.1111\/ene.16073","article-title":"European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain\u2013Barr\u00e9 syndrome.","volume":"30","author":"van Doorn","year":"2023;","journal-title":"Eur J Neurol"},{"issue":"(1):","key":"key20250627062116_B12","first-page":"57\u2013","article-title":"Phrenic nerve conduction study in the early stage of Guillain\u2013Barr\u00e9 syndrome as a predictor of respiratory failure.","volume":"21","author":"Sen","year":"2018;","journal-title":"Ann Indian Acad Neurol"},{"issue":"(10):","key":"key20250627062116_B13","first-page":"e23\u2013","article-title":"Claw hand in acute motor axonal neuropathy variant.","volume":"72","author":"Chozhan","year":"2024;","journal-title":"J Assoc Physicians India"},{"issue":"(9):","key":"key20250627062116_B14","first-page":"e14\u2013","article-title":"Correlation of clinical and electrophysiological criteria in the diagnosis of Guillain\u2013Barr\u00e9 syndrome: a prospective observational study.","volume":"72","author":"Samala","year":"2024;","journal-title":"J Assoc Physicians India"},{"issue":"(8):","key":"key20250627062116_B15","doi-asserted-by":"crossref","first-page":"e16365.","DOI":"10.1111\/ene.16365","article-title":"Guillain\u2013Barr\u00e9 syndrome: a comprehensive review.","volume":"31","author":"Bellanti","year":"2024;","journal-title":"Eur J Neurol"},{"issue":"(4):","key":"key20250627062116_B16","doi-asserted-by":"crossref","first-page":"300\u2013","DOI":"10.1136\/jnnp-2022-329937","article-title":"Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain\u2013Barr\u00e9 syndrome.","volume":"94","author":"Luijten","year":"2023;","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"(7):","key":"key20250627062116_B17","first-page":"11\u2013","article-title":"Clinical profile and outcome of patients presenting with Guillain\u2013Barr\u00e9 syndrome in a medical intensive care unit of a tertiary care hospital.","volume":"71","author":"Salagre","year":"2023;","journal-title":"J Assoc Physicians India"},{"issue":"(9047):","key":"key20250627062116_B18","first-page":"225\u2013","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain\u2013Barr\u00e9 syndrome. Plasma Exchange\/Sandoglobulin Guillain\u2013Barr\u00e9 Syndrome Trial Group.","volume":"349","year":"1997;","journal-title":"Lancet"},{"issue":"(17):","key":"key20250627062116_B19","doi-asserted-by":"crossref","first-page":"1123\u2013","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barr\u00e9 syndrome. Dutch Guillain\u2013Barr\u00e9 Study Group.","volume":"326","author":"van der Mech\u00e9","year":"1992;","journal-title":"N Engl J Med"},{"issue":"(10):","key":"key20250627062116_B20","first-page":"CD001446.","article-title":"Corticosteroids for Guillain\u2013Barr\u00e9 syndrome.","volume":"10","author":"Hughes","year":"2016;","journal-title":"Cochrane Database Syst Rev"},{"key":"key20250627062116_B21","doi-asserted-by":"crossref","first-page":"100468.","DOI":"10.1016\/j.ensci.2023.100468","article-title":"Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain\u2013Barr\u00e9 syndrome (GBS) in patients with severe symptoms: a systematic review and meta-analysis.","volume":"31:","author":"Zaki","year":"2023;","journal-title":"eNeurologicalSci"},{"key":"key20250627062116_B22","article-title":"Guillain\u2013Barr\u00e9 syndrome and other immune-mediated neuropathies.","volume-title":"Harrison\u2019s Principles of Internal Medicine.","author":"Hauser","year":"2022.","edition":"21st ed."},{"issue":"(6):","key":"key20250627062116_B23","doi-asserted-by":"crossref","first-page":"519\u2013","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of eculizumab in Guillain\u2013Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial.","volume":"17","author":"Misawa","year":"2018;","journal-title":"Lancet Neurol"},{"issue":"(S3):","key":"key20250627062116_B24","first-page":"S192\u2013","article-title":"Design of a phase 3 study evaluating ANX005 in patients with Guillain\u2013Barr\u00e9 syndrome.","volume":"29","author":"Kroon","year":"2024;","journal-title":"J Peripher Nerv Syst"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T06:21:25Z","timestamp":1751005285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-73-5-57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"alternative-id":["10.59556\/japi.73.0963"],"URL":"https:\/\/doi.org\/10.59556\/japi.73.0963","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}